We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Surgical Therapy Device Effectively Controls Acid Reflux Symptoms

By HospiMedica International staff writers
Posted on 16 Oct 2013
A minimally invasive surgical procedure, called magnetic sphincter augmentation (MSA), is a safe and effective option for relieving gastroesophageal reflux disease (GERD), according to a new study.

Researchers from the University of Milan (Italy) followed 100 consecutive patients who underwent laparoscopic MSA for GERD between 2007- 2012. More...
The patients had been treated with the LINX Reflux Management System to strengthen the weakened lower esophageal sphincter (LES), using a series of magnetic beads connected to each other by wires to form a ring shape. The researchers tracked clinical outcomes of esophageal pH measurements, symptoms scores, proton pump inhibitor use (PPI), and quality of life scores; for each patient, they then compared that data with presurgical data.

The study results showed that acid reflux was substantially reduced, with median total acid exposure time dropping from 8% before implantation to 3.2% following the procedure. In addition, 85% of GERD patients were able to eliminate their daily use of PPIs. Finally, patients reported an overall satisfaction with their quality of life, from 16 on the GERD Health Related Quality of Life score at baseline, 24 off PPIs, and upon last follow up an improvement to a score of just 2. The study was published in the October 2013 issue of the Journal of the American College of Surgeons.

“The main finding from our study is that MSA was very safe and well tolerated, and our patients were very satisfied with the procedure,” said lead author professor of surgery Luigi Bonavina, MD, of the University of Milan medical school. “MSA has become a standard treatment at our institution because control of reflux symptoms and pH normalization can be achieved with minimal side effects and preservation of gastric anatomy.”

In most GERD patients, the LES is weakened and does not close tightly, allowing digestive juices to return and irritate the esophageal lining. Treatment options include lifestyle changes and medications, such as over-the-counter antacids, proton pump inhibitors (PPIs), prescription medications, and a surgical fundoplication, where excess stomach tissue is folded around the esophagus and sewn in place to strengthen the LES.

The LINX Gastroesophageal Reflux Management System is a product of Torax Medical (St. Paul, MN, USA), and consists of a series of titanium beads, each with a magnetic core, connected together with independent titanium wires to form a ring shape; it is then placed laparoscopicaly around the LES. The force of the magnetic beads is designed to provide additional strength to keep a weak LES closed, preventing the backward flow of stomach contents.

Related Links:

University of Milan
Torax Medical



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Electric Bed
DIXION Intensive Care Bed
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.